摘要
目的探讨中央坏死性乳腺癌(CNC)的临床病理特征、免疫表型和预后。方法收集2012年3月至2018年6月诊治的7例CNC的临床病理资料,并进行随访。结果7例患者年龄34~70岁,中位年龄52岁。大体均见单一结节。镜下肿瘤中央呈大片凝固性坏死或纤维化,癌组织呈窄带样环绕坏死区,6例为浸润性导管癌3级,1例为浸润性微乳头状癌伴浸润性导管癌2级结构。免疫组化染色显示,4例ER、PR、HER-2阴性,3例ER(+)、HER-2(+/++),基底细胞和肌上皮标记呈不同程度阳性。HER-2 FISH检测显示1例阳性。6例接受辅助治疗,术后随访14~49个月,其中4例无病生存,1例术后24个月出现肺转移,1例术后18个月出现肝转移,1例失访。结论CNC具有相对独特的病理组织学形态,大多为高级别浸润性导管癌并显示基底细胞样免疫表型。CNC预后较差,易发生肺、脑等远处转移,需严密监测。
Objective To investigate the clinicopathological features,immunophenotype and prognosis of centrally necrotizing carcinoma of breast(CNC).Methods The clinicopathological data of 7 cases of CNC diagnosed from March 2012 to June 2018 were collected,and the prognosis was followed-up.Results The age of 7 patients was 34-70 years,and the median age was 52 years.All tumors presented a single well-circumscribed nodule in gross examination.Microscopically,a large area of coagulative necrosis or fibrosis was found in the center of the tumor,and the tumor tissues showed a narrow band surrounding the necrotic area.Six cases were grade 3 invasive ductal carcinoma and 1 case was invasive micropapillary carcinoma with grade 2 structure of invasive ductal carcinoma.Immunohistochemical results showed that 4 cases were negative for ER,PR and HER-2.Three cases were positive for ER and HER-2(+/++).Basal cells and myoepithelial markers were positive in varying degrees.HER-2 FISH test showed one positive case.Six surgical cases were followed up for 14-49 months,of whom 4 cases survived without disease,1 case had lung metastasis 24 months after operation,1 case had liver metastasis 18 months after operation,and 1 outpatient surgical case was lost follow-up.Conclusion CNC has a relatively specific histopathological morphology,most of which is high-grade invasive ductal carcinoma and displays basal cell like immunophenotype.The prognosis of CNC is poor,and it is prone to distant metastasis,which needs close monitoring.
作者
龙卫国
郑芳
庄莹
李梅
王文欣
钟安菁
赵小辉
吴建农
LONG Weiguo;ZHENG Fang;ZHUANG Ying;LI Mei;WANG Wenxin;ZHONG Anjing;ZHAO Xiaohui;WU Jiannon(Department of Pathology,Affiliated Hospital of Jiangsu University,Zhenjiang 212000,China)
出处
《临床肿瘤学杂志》
CAS
2023年第7期637-641,共5页
Chinese Clinical Oncology
关键词
乳腺肿瘤
中央坏死性
免疫表型
预后
Brest carcinoma
Centrally necrotizing carcinoma
Immunophenotype
Prognosis